Giddapahar Darjeeling (Camellia sinensis 'Giddapahar')

Giddapahar Darjeeling is a clonal tea cultivar (Camellia sinensis) developed at the Giddapahar Tea Research Centre in Darjeeling, India, prized for its distinctive muscatel flavor profile attributed to its unique polyphenol and volatile compound composition. Like other Camellia sinensis cultivars, it contains catechins such as epigallocatechin gallate (EGCG), L-theanine, and caffeine, though no cultivar-specific clinical research has been conducted to establish independent therapeutic claims.

Category: Tea Cultivars Evidence: 2/10 Tier: Traditional
Giddapahar Darjeeling (Camellia sinensis 'Giddapahar') — Hermetica Encyclopedia

Origin & History

Giddapahar Darjeeling is a specific cultivar variant of Camellia sinensis grown at Giddapahar Tea Estate in West Bengal, India, at elevations around 4,900 feet. Established in 1888 by the Indian Shah family, the estate cultivates primarily China bush variety (75%), with leaves hand-plucked every 5-10 days and processed into black tea through withering and oxidation.

Historical & Cultural Context

Giddapahar Darjeeling has no documented historical use in traditional medicine systems. It originated from commercial cultivation in 1888, focusing on beverage production rather than medicinal applications, lacking ties to Ayurveda or Traditional Chinese Medicine.

Health Benefits

• No clinical health benefits documented - no human studies found in research
• No RCTs or meta-analyses available for this specific cultivar
• No evidence-based therapeutic effects established
• General Camellia sinensis benefits cannot be extrapolated without cultivar-specific data
• Evidence quality: None - no clinical trials identified

How It Works

Giddapahar Darjeeling, as a Camellia sinensis cultivar, is presumed to share general tea polyphenol mechanisms, whereby EGCG inhibits catechol-O-methyltransferase (COMT) and modulates PI3K/Akt signaling pathways linked to antioxidant defense. L-theanine promotes alpha-wave brain activity by antagonizing glutamate NMDA receptors and facilitating GABA synthesis, while caffeine non-selectively blocks adenosine A1 and A2A receptors to produce stimulatory effects. The specific polyphenol ratios and volatile terpenoids unique to this cultivar have not been mapped to distinct molecular targets in peer-reviewed literature.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Giddapahar Darjeeling were identified in the research. The search yielded no PubMed PMIDs, study designs, sample sizes, or clinical outcomes for this cultivar variant.

Clinical Summary

No human clinical trials, randomized controlled trials, or meta-analyses exist for the Giddapahar Darjeeling cultivar specifically, making it impossible to establish evidence-based therapeutic outcomes for this variety. General Camellia sinensis research cannot be reliably extrapolated to this cultivar, as polyphenol concentrations, catechin ratios, and bioactive volatile profiles vary significantly between clonal varieties and growing conditions. Broader green and black tea research suggests associations between EGCG intake (400–800 mg/day in supplemental studies) and modest cardiovascular and cognitive benefits, but these findings do not apply to Giddapahar without cultivar-specific data. The current evidence quality for this specific cultivar is effectively absent, placing it at the lowest tier of evidence-based supplementation.

Nutritional Profile

Giddapahar Darjeeling is a clonal tea cultivar from the Giddapahar Tea Estate in Darjeeling, India, yielding brewed tea with a compositional profile characteristic of high-altitude Camellia sinensis first-flush productions, though cultivar-specific quantitative data remains unpublished in peer-reviewed literature. Based on structural analogy to characterized Darjeeling clonal cultivars at comparable elevations (1,500–2,000m): Catechins (primary bioactives): estimated total catechins 120–180mg per 200ml brew, with epigallocatechin gallate (EGCG) likely comprising 40–60% of catechin fraction (~60–100mg/200ml), epigallocatechin (EGC) ~20–30mg/200ml, epicatechin gallate (ECG) ~15–25mg/200ml, epicatechin (EC) ~10–20mg/200ml; high-altitude growth and muscatel character suggest elevated theaflavin precursor potential. Caffeine: approximately 30–50mg per 200ml serving, consistent with Darjeeling first-flush profiles. L-theanine: estimated 15–35mg per 200ml brew; the cultivar's noted complexity suggests a potentially favorable theanine-to-caffeine ratio, though unconfirmed. Polyphenols (total): estimated 150–250mg gallic acid equivalents per 200ml. Flavonols: quercetin glycosides, kaempferol, and myricetin derivatives present at trace-to-low concentrations (combined ~5–15mg/200ml). Terpene compounds: linalool, geraniol, and hotrienol reported as contributors to Darjeeling muscatel aroma profile; concentrations in parts-per-billion range, negligible nutritional contribution. Minerals per 200ml brew: fluoride 0.1–0.3mg, manganese 0.3–0.6mg, potassium 20–40mg, magnesium 1–3mg, trace zinc and copper. Vitamins: minimal; trace B-complex vitamins including riboflavin (<0.05mg/200ml). Macronutrients per 200ml unsweetened brew: calories ~2–4kcal, carbohydrates <1g (primarily from soluble polysaccharides), protein <0.5g (amino acid fraction including theanine, glutamic acid, arginine), fat negligible (<0.1g). Dietary fiber: negligible in liquid form; insoluble fiber present in leaf material if consumed whole. Bioavailability notes: catechin absorption estimated at 20–30% from brewed tea; co-consumption with milk reduces catechin bioavailability by competitive binding; lemon/ascorbic acid addition may modestly improve catechin stability; the high tannin content characteristic of Darjeeling first-flush may further limit mineral (iron, zinc) absorption when consumed with meals. All values are estimated from comparable Darjeeling cultivar literature; Giddapahar-specific analytical data has not been published.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available for Giddapahar Darjeeling, as no relevant clinical studies exist. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

General Camellia sinensis varieties, Green tea extract, L-theanine, EGCG, Caffeine

Safety & Interactions

As a Camellia sinensis cultivar, Giddapahar Darjeeling tea consumed in normal dietary quantities (2–4 cups per day) is generally regarded as safe for healthy adults, though concentrated extracts may cause hepatotoxicity at high EGCG doses exceeding 800 mg/day, as flagged by the European Food Safety Authority. Caffeine content warrants caution in individuals with anxiety disorders, cardiac arrhythmias, or hypertension, and may interact with stimulant medications, anticoagulants such as warfarin (due to vitamin K content in leaf preparations), and MAO inhibitors. Pregnant or breastfeeding individuals should limit intake to minimize caffeine and tannin exposure, as high tannin levels can impair iron absorption. No cultivar-specific drug interaction data exists for Giddapahar Darjeeling.